中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [7]
金属研究所 [6]
合肥物质科学研究院 [6]
上海神经科学研究所 [3]
长春应用化学研究所 [2]
苏州纳米技术与纳米仿... [1]
更多
采集方式
OAI收割 [32]
iSwitch采集 [1]
内容类型
期刊论文 [33]
发表日期
2024 [1]
2022 [1]
2021 [2]
2019 [1]
2018 [1]
2017 [3]
更多
学科主题
Cell Biolo... [2]
Biochemist... [1]
Chemistry,... [1]
Life Scien... [1]
Oncology [1]
Polymer Sc... [1]
更多
筛选
浏览/检索结果:
共33条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial
期刊论文
OAI收割
ECLINICALMEDICINE, 2024, 卷号: 76
作者:
Yan, Min
;
Ouyang, Quchang
;
Sun, Tao
;
Niu, Limin
;
Yang, Jin
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2024/11/20
Pyrotinib
Human epidermal growth factor receptor 2
Breast cancer
Brain metastases
Overall survival
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
OAI收割
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
  |  
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway
期刊论文
OAI收割
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021
作者:
Qi, Yajun
;
Fang, Qilu
;
Li, Qinglin
;
Ding, Haiying
;
Shu, Qi
  |  
收藏
  |  
浏览/下载:94/0
  |  
提交时间:2021/09/06
Hepatocellular carcinoma (HCC)
myeloid differentiation protein 2 (MD2)
epidermal growth factor receptor (EGFR)
migration
invasion
Risk evaluation of early-stage hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer patients: a population-based study from Taiwan
期刊论文
OAI收割
BREAST CANCER RESEARCH AND TREATMENT, 2021
作者:
Lei, Lei
;
Chan, Han-Ching
;
Lu, Tzu-Pin
;
Cheng, Skye Hung-Chun
  |  
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2021/08/30
Human epidermal growth factor receptor 2
Breast cancer
Dutch criteria
Taiwan
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC
期刊论文
OAI收割
Aging-Us, 2019, 卷号: 11, 期号: 23, 页码: 11054-11072
作者:
Y.Liu
;
Y.H.Zhou
;
K.H.Huang
;
Y.Li
;
X.J.Fang
  |  
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2020/08/24
triple-negative breast cancer,human epidermal growth factor receptor,chimeric antigen receptor engineered T cells,negative breast-cancer,growth-factor receptor,therapy,amplification,inhibition,expression,challenges,mutations,her2,Cell Biology,Geriatrics & Gerontology
Diagnostic Value of ER, PR, FR and HER-2-Targeted Molecular Probes for Magnetic Resonance Imaging in Patients with Breast Cancer
期刊论文
OAI收割
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 卷号: 49, 期号: 1, 页码: 271-281
作者:
Dai, Qi
;
Jin, Yin-Hua
;
Hua, Qi-Feng
;
Zheng, Jian-Jun
;
Ma, Xue-Hua
  |  
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2018/12/04
Growth-factor Receptor-2
Estrogen-receptor
Progesterone-receptor
In-vivo
Folate Receptor
Postmenopausal Women
Expression
Subtypes
Cells
Chemotherapy
Single-molecule imaging reveals the stoichiometry change of epidermal growth factor receptor during transactivation by beta(2)-adrenergic receptor
期刊论文
OAI收割
SCIENCE CHINA-CHEMISTRY, 2017, 卷号: 60, 期号: 10, 页码: 1310-1317
作者:
Zhang, Mingliang
;
He, Kangmin
;
Wu, Jimin
;
Li, Nan
;
Yuan, Jinghe
  |  
收藏
  |  
浏览/下载:81/0
  |  
提交时间:2018/04/25
Transactivation
Epidermal Growth Factor Receptor (Egfr)
Beta(2)-adrenergic Receptor (Beta(2)-ar)
Single Molecule Imaging
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents
期刊论文
OAI收割
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:
Zhang Lan
;
Deng Xinshan
;
Wu Jiaofeng
;
Meng Guangpeng
;
Liu Congchong
  |  
收藏
  |  
浏览/下载:63/0
  |  
提交时间:2021/02/02
MOLECULAR TARGETED DRUGS
TYROSINE KINASE
CANCER-CELLS
EGFR
RESISTANCE
POTENT
DISCOVERY
NSCLC
Anticancer activity
Epidemal growth factor receptor(EGFR) inhibitor
N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents
期刊论文
OAI收割
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:
Zhang Lan
;
Deng Xinshan
;
Wu Jiaofeng
;
Meng Guangpeng
;
Liu Congchong
  |  
收藏
  |  
浏览/下载:60/0
  |  
提交时间:2021/02/02
MOLECULAR TARGETED DRUGS
TYROSINE KINASE
CANCER-CELLS
EGFR
RESISTANCE
POTENT
DISCOVERY
NSCLC
Anticancer activity
Epidemal growth factor receptor(EGFR) inhibitor
N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative
Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling
期刊论文
OAI收割
ONCOTARGET, 2016, 卷号: 7, 期号: 50, 页码: 82820-82835
作者:
Zhou, Xunian
;
Yue, Grace Gar-Lee
;
Liu, Minghua
;
Zuo, Zhili
;
Lee, Julia Kin-Ming
收藏
  |  
浏览/下载:249/0
  |  
提交时间:2017/02/28
Eriocalyxin B
angiogenesis
vascular endothelial growth factor (VEGF)
vascular endothelial growth factor receptor 2(VEGFR-2)
breast cancer